Ayala Pharmaceuticals, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kost Forer Gabbay & Kasierer, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2905 USD | +7.60% | +9.62% | -56.45% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.45% | 11.51M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt